<unk> , a close structural analogue of latrepirdine, is a selective 5-HT6 receptor antagonist which is under development by Avineuro Pharmaceuticals for the treatment of Alzheimer's disease and anxiety disorders. As of November 2013, it is in phase II clinical trials for these indications.
AVN-101
AVN-211
RVT-802
ORG-2058
Co-codaprin
EA-4056
MK-2048
SHIRPA